©Author(s) (or their employer(s)) 2026.
World J Clin Cases. Mar 6, 2026; 14(7): 117431
Published online Mar 6, 2026. doi: 10.12998/wjcc.v14.i7.117431
Published online Mar 6, 2026. doi: 10.12998/wjcc.v14.i7.117431
Table 1 Routine blood tests
| Parameter (units) | Day 1 | Day 3 | Day 5 | Day 7 | Day 11 | Day 14 | Day 30 |
| Hemoglobin (g/dL) | 4.3 | 6.8 | 9.4 | 9.4 | 8.2 | 7.7 | 9.0 |
| Total leucocyte count (cells/cubic mm) | 11370 | 21700 | 11500 | 14400 | 12600 | 15000 | 21600 |
| Differential leucocyte count (neutrophil/Lymphocyte) (%) | 90/7 | 80/10 | 93/3 | 83/2 | 87/8 | 87/0.6 | 93/4 |
| Platelet (cells/cubic mm) | 60000 | 60000 | 52000 | 60000 | 100000 | 220000 | 100000 |
| Bilirubin (total/direct) (mg/dL) | 0.5 | 2.8/0.6 | 1.9/0.7 | 1.2/0.4 | 1.4/0.4 | 2.5/0.5 | 2/0.5 |
| Total protein (g/dL) | - | 4.3 | 4.7 | 5.0 | 5.9 | 5.3 | 5.2 |
| Albumin (g/dL) | 3.1 | 2.6 | 2.7 | 2.6 | 3.8 | 3.7 | 2.7 |
| Globulin (g/dL) | - | 1.7 | 2.0 | 2.4 | 2.1 | 1.6 | 2.5 |
| ALT (IU/L) | 32 | 60 | 60 | 52 | 42 | 19 | 30 |
| AST (IU/L) | 58 | 122 | 73 | 64 | 39 | 31 | 53 |
| ALP (IU/L) | 65 | 87 | 92 | 89 | 69 | 65 | 64 |
| PT (second) | 13.4 | 14.5 | - | 12.0 | 25.0 | 20.0 | 16.0 |
| INR | 0.95 | 1.25 | - | 1.03 | 0.90 | 0.80 | 1.11 |
| Urea (mg/dL) | 28 | 63 | 36 | 28 | - | - | 13 |
| Creatinine (mg/dL) | 0.9 | 0.9 | 0.8 | 1.0 | - | - | 0.4 |
| Sodium (mEq/L) | 135 | 143 | 147 | 135 | 142 | - | 131 |
| Potassium (mEq/L) | 5.5 | 3.6 | 3.1 | 4.3 | 3.7 | - | 3.9 |
Table 2 Analysis of pleural fluid and ascitic fluid
| Parameter (units) | Ascitic fluid | Pleural fluid |
| Total protein (g/dL) | 0.6 | 0.4 |
| Total albumin (g/dL) | 0.3 | 0.3 |
| Total cell count | 150 (neutrophil 60%, lymphocyte 30%, mesothelial cells 10%) | 80 (neutrophil 20%, lymphocyte 50%, mesothelial cells 30%) |
Table 3 Coagulation profile
| Parameter | Observed value | Reference interval |
| PT | 14.5 s | 11.0-15.0 s |
| aPTT | 32 s | 25-35 s |
| INR | 1.25 | 0.80-1.20 |
| Thrombin time | 17 s | 14-19 s |
| Fibrinogen | 283 mg/dL | 200-400 mg/dL |
| D-Dimer | 1.30 µFEU/mL | < 0.5 µFEU/mL |
| Protein C, % | 42 | 70-140 |
| Protein S, % | 18 | 60-150 |
| Antithrombin III, % | 62 | 80-130 |
| Von Willebrand factor, % | 100 | 50-160 |
| Factor V Leiden mutation | Absent | - |
| Lupus anticoagulant | Negative | - |
- Citation: Dhali A, Maity R, Sinha A, Singh P, Biswas J, Dhali GK. Combined anticoagulant deficiency causing extrahepatic portal venous obstruction: A case report. World J Clin Cases 2026; 14(7): 117431
- URL: https://www.wjgnet.com/2307-8960/full/v14/i7/117431.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i7.117431
